The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells

References

• Scheau C, Caruntu C, Badarau IA, et al. Cannabinoids and inflammations of the gut-lung-skin barrier. J Pers Med. 2021;11(6):254. doi:10.3390/jpm11060494
   PubMed Web of Science ®Google Scholar
• Stasiulewicz A, Znajdek K, Grudzien M, Pawinski T, Sulkowska AJI. A guide to targeting the endocannabinoid system in drug design. Int J Mol Sci. 2020;21(8):2778. doi:10.3390/ijms21082778
   PubMed Web of Science ®Google Scholar
• Lopez Trinidad LM, Martinez R, Kapravelou G, et al. Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats. Sci Rep. 2021;11(1):4286. doi:10.1038/s41598-021-83709-9
   PubMed Web of Science ®Google Scholar
• Pepper I, Vinik A, Lattanzio F, McPheat W, Dobrian A. Countering the modern metabolic disease rampage with ancestral endocannabinoid system alignment. Front Endocrinol (Lausanne). 2019;10:311. doi:10.3389/fendo.2019.00311
   PubMed Web of Science ®Google Scholar
• Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998;83(2):393–411. doi:10.1016/S0306-4522(97)00436-3
   PubMed Web of Science ®Google Scholar
• Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010;126(1):21–38.
   PubMed Web of Science ®Google Scholar
• Starowicz KM, Cristino L, Matias I, et al. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity. 2008;16(3):553–565. doi:10.1038/oby.2007.106
   PubMed Web of Science ®Google Scholar
• Liu QR, Pan CH, Hishimoto A, et al. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav. 2009;8(5):519–530. doi:10.1111/j.1601-183X.2009.00498.x
   PubMed Web of Science ®Google Scholar
• Brown SM, Wager-Miller J, Mackie K. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta. 2002;1576(3):255–264. doi:10.1016/S0167-4781(02)00341-X
   PubMedGoogle Scholar
• Klein TW, Newton C, Larsen K, et al. The cannabinoid system and immune modulation. J Leukoc Biol. 2003;74(4):486–496. doi:10.1189/jlb.0303101
   PubMed Web of Science ®Google Scholar
• Haddad M. Do CB1 cannabinoid receptors regulate insulin signalling in rat primary skeletal muscle cells? J Phys Pharm Adv. 2013;3(12):277–291.
   Google Scholar
• Haddad M. What does rimonabant do in rat primary skeletal muscle cells? Biomed Pharmacol J. 2014;7(1):81–92. doi:10.13005/bpj/455
   Google Scholar
• Wang Q, Perrard XD, Perrard JL, et al. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity. Obesity. 2011;19(3):505–513. doi:10.1038/oby.2010.213
   PubMed Web of Science ®Google Scholar
• Haspula D, Clark MA. Contrasting Roles of Ang II and ACEA in the Regulation of IL10 and IL1beta Gene Expression in Primary SHR Astroglial Cultures. Molecules. 2021;26:10. doi:10.3390/molecules26103012
   Web of Science ®Google Scholar
• Joffre J, Yeh CC, Wong E, et al. Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury. J Immunol. 2020;204(12):3339–3350. doi:10.4049/jimmunol.2000213
   PubMed Web of Science ®Google Scholar
• Zawatsky CN, Abdalla J, Cinar R. Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation. ERJ Open Res. 2020;6(3):00121–2020. doi:10.1183/23120541.00121-2020
   PubMedGoogle Scholar
• Laitano O, Robinson GP, Garcia CK, et al. Skeletal Muscle Interleukin-6 Contributes to the Innate Immune Response in Septic Mice. Shock. 2021;55(5):676–685. doi:10.1097/SHK.0000000000001641
   PubMed Web of Science ®Google Scholar
• Villar-Fincheira P, Sanhueza-Olivares F, Norambuena-Soto I, et al. Role of interleukin-6 in vascular health and disease. Front Mol Biosci. 2021;8:641734. doi:10.3389/fmolb.2021.641734
   PubMed Web of Science ®Google Scholar
• Greco L, Russo V, Rapino C, et al. Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response. Cells. 2020;9(4):1008. doi:10.3390/cells9041008
   PubMed Web of Science ®Google Scholar
• Remels AH, Gosker HR, van der Velden J, Langen RC, Schols AM. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med. 2007;28(3):537–552. doi:10.1016/j.ccm.2007.06.003
   PubMed Web of Science ®Google Scholar
• Londhe P, Guttridge DC. Inflammation induced loss of skeletal muscle. Bone. 2015;80:131–142. doi:10.1016/j.bone.2015.03.015
   PubMed Web of Science ®Google Scholar
• Begue G, Douillard A, Galbes O, et al. Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS One. 2013;8(2):e57141. doi:10.1371/journal.pone.0057141
   PubMed Web of Science ®Google Scholar
• Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7(1):33–44. doi:10.1016/j.cmet.2007.11.011
   PubMed Web of Science ®Google Scholar
• Steyn PJ, Dzobo K, Smith RI, Myburgh KH. Interleukin-6 Induces Myogenic Differentiation via JAK2-STAT3 Signaling in Mouse C2C12 Myoblast Cell Line and Primary Human Myoblasts. Int J Mol Sci. 2019;20:21. doi:10.3390/ijms20215273
   Web of Science ®Google Scholar
• Hoene M, Runge H, Haring HU, Schleicher ED, Weigert C. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway. Am J Physiol Cell Physiol. 2013;304(2):C128–36. doi:10.1152/ajpcell.00025.2012
   PubMed Web of Science ®Google Scholar
• Nagappan A, Shin J, Jung MH. Role of cannabinoid receptor type 1 in insulin resistance and its biological implications. Int J Mol Sci. 2019;20(9):2109. doi:10.3390/ijms20092109
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mariscal I, Montoro RA, Doyle ME, et al. Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets. Diabetologia. 2018;61(6):1470–1483. doi:10.1007/s00125-018-4576-4
   PubMed Web of Science ®Google Scholar
• Kim Y, Gautam S, Aseer KR, et al. Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-kappaB signaling. Cell Death Dis. 2020;11(12):1044. doi:10.1038/s41419-020-03261-8
   PubMed Web of Science ®Google Scholar
• Matias I, Gonthier MP, Orlando P, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab. 2006;91(8):3171–3180. doi:10.1210/jc.2005-2679
   PubMed Web of Science ®Google Scholar
• Bluher M, Engeli S, Kloting N, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes. 2006;55(11):3053–3060. doi:10.2337/db06-0812
   PubMed Web of Science ®Google Scholar
• Parker J, Atez F, Rossetti RG, Skulas A, Patel R, Zurier RB. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. Rheumatol Int. 2008;28(7):631–635. doi:10.1007/s00296-007-0489-0
   PubMed Web of Science ®Google Scholar
• De Petrocellis L, Orlando P, Moriello AS, et al. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol. 2012;204(2):255–266. doi:10.1111/j.1748-1716.2011.02338.x
   PubMed Web of Science ®Google Scholar
• Haddad. M. mRNA expression of GPCRs in rat skeletal muscle tissues. Int J Biol Pharm Allied Sc. 2014;3(10):2506–2536.
   Google Scholar
• Lindborg KA, Jacob S, Henriksen EJ. Effects of chronic antagonism of endocannabinoid-1 receptors on glucose tolerance and insulin action in skeletal muscles of lean and obese Zucker rats. Cardiorenal Med. 2011;1(1):31–44. doi:10.1159/000322826
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Manna S, Greenberg MJ, et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther. 1999;289(3):1427–1433.
   PubMed Web of Science ®Google Scholar
• Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994;350(2–3):240–244. doi:10.1016/0014-5793(94)00773-X
   PubMed Web of Science ®Google Scholar
• Glund S, Deshmukh A, Long YC, et al. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes. 2007;56(6):1630–1637. doi:10.2337/db06-1733
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812–817. doi:10.2337/diabetes.52.3.812
   PubMed Web of Science ®Google Scholar
• Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006;55(10):2688–2697. doi:10.2337/db05-1404
   PubMed Web of Science ®Google Scholar
• Petrella C, Agostini S, Alema GS, et al. Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis. Neurogastroenterol Motil. 2010;22(11):1248–1256. doi:10.1111/j.1365-2982.2010.01569.x
   PubMed Web of Science ®Google Scholar
• Molina-Holgado F, Molina-Holgado E, Guaza C. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler’s murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett. 1998;433(1–2):139–142. doi:10.1016/S0014-5793(98)00851-5
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mariscal I, Montoro RA, O’Connell JF, et al. Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism. FASEB J. 2019;33(5):5850–5863. doi:10.1096/fj.201801145R
   PubMed Web of Science ®Google Scholar
• Iannotti FA, Pagano E, Guardiola O, et al. Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. Nat Commun. 2018;9(1):3950. doi:10.1038/s41467-018-06267-1
   PubMedGoogle Scholar
• Millward DJ, Garlick PJ, James WP, Nnanyelugo DO, Ryatt JS. Relationship between protein synthesis and RNA content in skeletal muscle. Nature. 1973;241(5386):204–205. doi:10.1038/241204a0
   PubMed Web of Science ®Google Scholar
• Scheler M, Irmler M, Lehr S, et al. Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol. 2013;305(8):C877–86. doi:10.1152/ajpcell.00043.2013
   PubMed Web of Science ®Google Scholar
• LaPensee CR, Hugo ER, Ben-Jonathan N. Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways. Endocrinology. 2008;149(11):5415–5422. doi:10.1210/en.2008-0549
   PubMed Web of Science ®Google Scholar
• Chou CH, Wei LH, Kuo ML, et al. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Carcinogenesis. 2005;26(1):45–52. doi:10.1093/carcin/bgh301
   PubMed Web of Science ®Google Scholar
• Haddad M. Impact of Adenosine Analogue, Adenosine-5’-N-Ethyluronamide (NECA), on Insulin Signaling in Skeletal Muscle Cells. Biomed Res Int. 2021;2021:9979768
   Google Scholar
• Haddad M. Impact of Adenosine A2 Receptor Ligands on BCL2 Expression in Skeletal Muscle Cells. Applied Sciences. 2021;11(5).
   Google Scholar